NDC 67457-486-04 - Methotrexate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67457-486
- Requested NDC
- 67457-486-04
- Package NDCs from labels
- 67457-486-04, 67457-486-99
- Manufacturer
- Mylan Institutional LLC
- Effective date
- 2019-11-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methotrexate - Mylan Institutional LLC | Mylan Institutional LLC | 2019-11-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 67457-486-04 | ML - Milliliter | 67457-486 | 51b38a4e-749f-40a7-84ee-b7ac22adf9ef | 1 | 2014-09-03 |
| 67457-486-99 | ML - Milliliter | 67457-486 | 724b9039-1f35-4b1f-946b-113ba3588435 | 1 | 2014-09-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE INJECTION [MYLAN INSTITUTIONAL LLC ] | 2 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE INJECTION [MYLAN INSTITUTIONAL LLC ] | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | METHOTREXATE INJECTION [MYLAN INSTITUTIONAL LLC ] | 2 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | METHOTREXATE INJECTION [MYLAN INSTITUTIONAL LLC ] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | METHOTREXATE INJECTION [MYLAN INSTITUTIONAL LLC ] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methotrexate | METHOTREXATE SODIUM | Sun Pharmaceutical Industries, Inc. | 8f1260de-b60c-4f0e-8af6-0e957b0a281b | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 3IG1E710ZN |
| Methotrexate Sodium | METHOTREXATE SODIUM | Hikma Pharmaceuticals USA Inc. | d71b1856-99d8-4a9e-9189-f87b6675f80a | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 3IG1E710ZN |
| Methotrexate | METHOTREXATE | Bryant Ranch Prepack | 4741a44f-0d0b-4380-84f6-231a8d1560fb | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 3IG1E710ZN |
| Sodium Chloride | SODIUM CHLORIDE | Hospira, Inc. | a2a964f7-c3ec-4dfb-e3a0-6d8136a80397 | 2026-05-19 | Warnings, Adverse reactions | 451W47IQ8X |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643bc58-bb0e-5c79-e053-2991aa0a02ae | 2026-05-19 | Warnings | QTT17582CB |
| METHOTREXATE | METHOTREXATE | Alembic Pharmaceuticals Inc. | 04a95db9-a124-4b97-bd71-1c37a6b3b0c8 | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | 3IG1E710ZN |
| Herplex | ANATHERUM MURICATUM, CLEMATIS ERECTA, MEZEREUM, PHYTOLACCA DECANDRA, RANUNCULUS BULBOSUS, RHUS TOX, THUJA OCCIDENTALIS, NATRUM MURIATICUM, SEPIA | Nashco Products LLC | e5e7aa2f-3697-4747-9045-670ea2b13557 | 2026-05-14 | Warnings | 451W47IQ8X |
| NebuClear MD | SALINE | Blue Echo Care LLC | 3f85fe62-230f-b0f1-e063-6394a90a5cb8 | 2026-05-11 | Warnings | 451W47IQ8X |
| Acne Relief | BELLADONNA, SILICEA, GRAPHITES, HEPAR SULPHURIS CALCAREUM, KALI BROMATUM, LEDUM PALUSTRE, NATRUM MURIATICUM, SELENIUM, SULPHUR | NaturalCare | 487b1373-b78c-4510-964a-6ab0fe781ff4 | 2026-05-08 | Warnings | 451W47IQ8X |
| Methotrexate | METHOTREXATE | Mylan Pharmaceuticals Inc. | 70c09984-2b36-424f-8b27-3fd0cd4e833d | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | 3IG1E710ZN |
| Migraine Relief | BELLADONNA, BRYONIA (ALBA), CHAMOMILLA, CIMICIFUGA RACEMOSA, COFFEA CRUDA, GLONOINUM, IRIS VERSICOLOR, NATRUM MURIATICUM, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS | The Magni Company | 79b25c52-e145-4ee5-af2e-1ccf6ad5ac2d | 2026-05-07 | Warnings | 451W47IQ8X |
| Methotrexate | METHOTREXATE | Aurobindo Pharma Limited | 09931d44-a3f8-49dc-a3f2-b527ee4214bf | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | 3IG1E710ZN |
| Viril | BENZOICUM ACIDUM, CALADIUM SEGUINUM, CHIMAPHILA UMBELLATA, CLEMATIS ERECTA, RHODODENDRON, SABAL SERRULATA, NATRUM MURIATICUM, CORTISONE ACETICUM, HYPOTHALAMUS SUIS, PROSTATE (SUIS), TESTOSTERONE, AGNUS CASTUS, AURUM METALLICUM, BRYONIA (ALBA), CONIUM MACULATUM, LYCOPODIUM CLAVATUM, SELENIUM METALLICUM, SEPIA, THUJA OCCIDENTALIS, KALI ARSENICOSUM, BUFO RANA | Deseret Biologicals, Inc. | 3701cc0d-91ed-45fd-98b8-9d8cfba9c787 | 2026-05-06 | Warnings | 451W47IQ8X |
| Methotrexate | METHOTREXATE | NuCare Pharmaceuticals, Inc. | 50b2cfc7-dfe4-4406-e063-6294a90a2527 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 3IG1E710ZN |
| Sodium Chloride | SODIUM CHLORIDE | Sportpharm LLC | a2c111f6-74d5-4a5d-82ac-d0f237488cb8 | 2026-04-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Method Pharmaceuticals, LLC | 4b08859e-65bd-8255-e063-6394a90af614 | 2026-04-23 | Warnings | 451W47IQ8X |
| Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical, Inc. | a926f913-18fa-4a3e-bfd6-210e1e427960 | 2026-04-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Cardioforce II | ABROTANUM, BOLDO, CIMICIFUGA RACEMOSA, KALI PHOSPHORICUM, TARAXACUM OFFICINALE, CONVALLARIA MAJALIS, MAGNESIA SULPHURICA, OLEANDER, NATRUM MURIATICUM, BELLIS PERENNIS | BioActive Nutritional, Inc. | 733bbb26-7698-4a1b-9dc8-7e3490ffc92b | 2026-04-17 | Warnings | 451W47IQ8X |
| Thyroid HP | BARYTA CARBONICA, CALCAREA CARBONICA, FUCUS VESICULOSUS, IODIUM, NATRUM MURIATICUM, PULSATILLA, SPONGIA TOSTA, THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 3795820a-cf2a-4094-9a02-70e3757b7510 | 2026-04-17 | Warnings | 451W47IQ8X |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.